Introgen Therapeutics Inc

CIK 1018710 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Introgen Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Mar 16, 2009NT 10-K0000950134-09-005404
Mar 12, 200915-12G0000950134-09-005074
Mar 9, 2009POS AM0000950134-09-004740
Mar 9, 2009S-8 POS0000950134-09-004732
Mar 9, 2009EFFECT9999999995-09-000533
Mar 9, 2009S-8 POS0000950134-09-004735
Mar 9, 2009POS AM0000950134-09-004743
Mar 9, 2009S-8 POS0000950134-09-004738
Mar 9, 2009EFFECT9999999995-09-000537
Mar 9, 2009S-8 POS0000950134-09-004737
Mar 9, 2009EFFECT9999999995-09-000534
Mar 9, 2009POS AM0000950134-09-004741
Mar 9, 2009S-8 POS0000950134-09-004731
Mar 9, 2009EFFECT9999999995-09-000540
Mar 9, 2009S-8 POS0000950134-09-004736
Mar 9, 2009S-8 POS0000950134-09-004739
Mar 9, 2009S-8 POS0000950134-09-004734
Mar 9, 2009POS AM0000950134-09-004742
Mar 9, 2009S-8 POS0000950134-09-004733
Feb 17, 2009SC 13G/A0000315066-09-001821
Feb 17, 200925-NSE0001354457-09-000038
Feb 17, 2009SC 13G/A0001422848-09-000278
Feb 17, 200950001426170-09-000001
Jan 30, 200915-12G0000950134-09-001492
Jan 13, 20098-K0000950134-09-000477